← Back to catalogue

ViperCath XC Peripheral Exchange Catheter

FDA 510(k)

Class II (US FDA 510(k))

510(k) K211251

by Cardiovascular Systems, Inc.

Identifiers

510(k) Number
K211251 FDA 510(k)
FDA Product Code
DQY FDA 510(k)

Classification

Device Class
Class II FDA 510(k)
Legislation / Framework
21 CFR Part 870.1250 FDA 510(k)
Regulation Number
870.1250 FDA 510(k)
Advisory Committee
Cardiovascular FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)

The ViperCath XC Peripheral Exchange Catheter is a peripheral vascular catheter designed for guidewire exchange during interventional and diagnostic procedures. It facilitates the transition of guidewires up to 0.035" in diameter within peripheral arteries, supporting both straight and angled configurations for enhanced vascular access.

This catheter is supplied sterile for single-use in clinical settings, including interventional radiology and vascular surgery. It is authorised under FDA 510(k) clearance (K211251) and classified under product code DQY, adhering to regulatory standards for peripheral vascular devices. Storage and handling follow standard sterile medical device protocols.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: DeviceMD - VIPERCATH™ XC PERIPHERAL EXCHANGE CATHETER, Vipercath XC Peripheral Exchange Catheter - Cardiovascular Systems ..., Peripheral Orbital Atherectomy Device Accessories | Abbott

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA 510(k) K211251 24 fields · synced Sep 19, 2026